Introduction
Pain in the oral and craniofacial system represents a major medical and social problem. Indeed, a U.S. Surgeon General's report on orofacial health concludes that, ''. . .oral health means much more than healthy teeth. It means being free of chronic oral-facial pain conditions. . . '' [172] . Community-based surveys indicate that many subjects commonly report pain in the orofacial region, with estimates of >39 million, or 22% of Americans older than 18 years of age, in the United States alone [108] . Other population-based surveys conducted in the United Kingdom [111, 112] , Germany [91], or regional pain care centers in the United States [54] report similar occurrence rates [135] . Importantly, chronic widespread body pain, patient sex and age, and psychosocial factors appear to serve as risk factors for chronic orofacial pain [1, 2, 92, 99, 138] . In addition to its high degree of prevalence, the reported intensities of various orofacial pain conditions are similar to that observed with many spinal pain disorders (Fig. 1) . Moreover, orofacial pain is derived from many unique target tissues, such as the meninges, cornea, tooth pulp, oral/ nasal mucosa, and temporomandibular joint (Fig. 2) , and thus has several unique physiologic characteristics compared with the spinal nociceptive system [23] . Given these considerations, it is not surprising that accurate diagnosis and effective management of orofacial pain conditions represents a significant health care problem.
Publications in the field of orofacial pain demonstrate a steady increase over the last several decades (Fig. 3 ). This is a complex literature; a recent bibliometric analysis of orofacial pain articles published in [2004] [2005] indicated that 975 articles on orofacial pain were published in 275 journals from authors representing 54 countries [142] . Thus, orofacial pain disorders represent a complex constellation of conditions with an equally diverse literature base. Accordingly, this review will focus on a summary of major research foci on orofacial pain without attempting to provide a comprehensive review of the entire literature.
Physiologic studies on trigeminal pain
Several reviews are available that document the historical development of physiologic research on the trigeminal nociceptive system [33, 53, 114, 120, 149] [90, 139] or second messenger signaling pathways [25] . Thus, the presence of unique target tissues innervated by trigeminal afferent fibers likely contributes to differences in the responsiveness of these neurons. A recent review characterizes differences between the trigeminal and spinal afferent systems under basal conditions [23] . Table 1 illustrates differences between the trigeminal and spinal systems after various forms of injury. Collectively, these studies indicate that the trigeminal system has many unique features that may contribute to distinct response patterns to tissue injury.
The hypothesis of peripheral regulation of neuronal phenotype has been expanded by the recognition that estradiol selectively alters gene transcription in trigeminal neurons with increased expression of neuropeptides, such as prolactin, that are capable of sensitizing neuronal responses to capsaicin or noxious heat [49] . Additional studies have demonstrated that trigeminal peptidergic neurons undergo morphological changes (''sprouting'') in response to injury-induced inflammation in target tissues [33] . In contrast, there is a lack of sympathetic fiber sprouting in trigeminal ganglion cells, unlike the well-recognized occurrence in the spinal system [19, 29, 63] . Thus, an emerging body of evidence reveals the dynamic and specific responsiveness of the trigeminal system to either injury of its various target tissues or to the presence of certain gonadal steroids.
Other studies have employed cultured trigeminal ganglia (TG) to evaluate cellular mechanisms of neuronal activation. For example, cannabinoids activate a calcineurin pathway leading to the rapid dephosphorylation and desensitization of transient receptor potential cation channel, subfamily V, member 1 (TRPV1), thereby contributing to an ionotropic mechanism for peripheral cannabinoid antinociception [4, 5, 89, 133] . Moreover, accumulating evidence indicates a functional cross-desensitization between TRPV1 and TRP subfamily A, member 1 (TRPA1) on trigeminal neurons, possibly via formation of a heteromer [4, 6, 146, 147] 
